Experience with the treatment of cryptococcal meningitis


Authors: J. Chmelař 1,2;  L.siráková 2;  P. Šmahel 1,2;  Š. Rumlarová 1,2;  S. Plíšek 1;  R. Chlíbek 2;  J. Smetana 2
Authors‘ workplace: Klinika infekčních nemocí LF UK a FN Hradec Králové 1;  Katedra epidemiologie, Hradec Králové, Fakulta vojenského zdravotnictví Univerzity obrany v Brně 2
Published in: Cesk Slov Neurol N 2022; 85(2): 189-190
Category: Letter to editor
doi: 10.48095/cccsnn2022189


Sources

1. Beneš J (ed). Kryptokokóza. In: Infekční lékařství. Praha: Galén 2009: 315.

2. Iyer KR, Revie NM, Fu C et al. Treatment strategies for cryptococcal infection: challenges, advances and future outlook. Nat Rev Microbiol 2021; 8: 1–13. doi: 10.1038/ s41579-021-00511-0.

3. Guess TE,Rosen J, Lopez NC et al. An inherent T cell deficit in healthy males to C. neoformans infection may begin to explain the sex incidenceof cryptococcosis. Biol Sex Differ 2019; 10: 44. doi: 10.1186/ s13293-019-0258-2.

4. Rajasingham R, Smith RM, Park BJ et al. Global burden of disease of HIV-associated cryptococcal meningitis: an update analysis. Lancet Infect Dis 2017; 17(8): 873–881. doi: 10.1016/ S1473-3099(17)30243-8.

5. Rozsypal H, Systémová antimykotika. Klin Farmakol Farm 2008; 22(1): 40–44.

6. Perfect JR, Dismukes WE, Dromer F et al. Clinical Practices guidelinesfor the managementof cryptoccocal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2010; 50(3): 291–322. doi: 10.1086/ 649858.

Labels
Paediatric neurology Neurosurgery Neurology

Article was published in

Czech and Slovak Neurology and Neurosurgery

Issue 2

2022 Issue 2

Most read in this issue
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account